Taken together, our results demonstrate that the “PVT1/miR-20a-5p/ULK1/autophagy” pathway modulates the development of PDA, indicating that this pathway is a novel target for developing therapeutic strategies to treat PDA. Here, PVT1 is linked to Patent ductus arteriosus.